₹1,499.60 35.60 (2.43%)
04:01 PM, 19-Feb-2025₹1,499.55 28.20 (1.92%)
03:50 PM, 19-Feb-2025BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 19-Feb-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 24,713 |
Traded Value (₹ Cr) | 0.96 |
Volume (Shares) | 6,399 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,220.95 |
52-Week High Date | 06-Aug-2024 |
52-Week Low (₹) | 1,412.00 |
52-Week Low Date | 12-Feb-2025 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 24,713 |
EPS - TTM (₹) [C] | 42.76 |
P/E Ratio (X) [C] | 35.07 |
Face Value (₹) | 1 |
Latest Dividend (%) | 2,000.00 |
Latest Dividend Date | 16-Aug-2024 |
Dividend Yield (%) | 1.33 |
Book Value Share (₹) [C] | 533.41 |
P/B Ratio (₹) [C] | 2.81 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Mid-Cap Opportunities Fund (G) | 846.53 | 55,51,922 | 1.15 |
HDFC Mid-Cap Opportunities Fund (IDCW) | 846.53 | 55,51,922 | 1.15 |
HDFC Mid-Cap Opportunities Fund - Direct (IDCW) | 846.53 | 55,51,922 | 1.15 |
HDFC Mid-Cap Opportunities Fund - Direct (G) | 846.53 | 55,51,922 | 1.15 |
Mirae Asset Large & Midcap Fund - Regular (G) | 562.22 | 36,87,292 | 1.54 |
Mirae Asset Large & Midcap Fund - Regular (IDCW) | 562.22 | 36,87,292 | 1.54 |
Mirae Asset Large & Midcap Fund - Direct (IDCW) | 562.22 | 36,87,292 | 1.54 |
Mirae Asset Large & Midcap Fund - Direct (G) | 562.22 | 36,87,292 | 1.54 |
SBI Large & Midcap Fund (G) | 442.18 | 29,00,000 | 1.54 |
SBI Large & Midcap Fund - Direct (G) | 442.18 | 29,00,000 | 1.54 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
04-Feb-2025 | Elara Capital | Buy | 1,841 | |
06-Nov-2024 | Motilal Oswal | Buy | 1,970 |
Today's Low/High (₹) | 1,443.15 1,503.85 |
Week Low/High (₹) | 1,411.10 1,512.00 |
Month Low/High (₹) | 1,411.10 1,725.00 |
Year Low/High (₹) | 1,411.10 2,221.00 |
All time Low/High (₹) | 861.50 4,350.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 1.24% | 1.41% | -0.30% | -0.49% |
1 Month | -10.69% | -10.70% | -0.89% | -1.16% |
3 Month | -15.68% | -15.90% | -2.11% | -2.49% |
6 Month | -23.44% | -23.53% | -5.58% | -6.67% |
1 Year | -25.07% | -25.03% | 4.44% | 3.66% |
3 Year | -53.42% | -53.39% | 31.31% | 32.74% |
Chairman & Independent Directo : Yiu Kwan Stanley Lau
Managing Director & CEO : SRINIVAS SADU
Non-Exec & Non-Independent Dir : UDO JAHANNES VETTER
Independent Director : C S N Murthy
Independent Director : ESSAJI GOOLAM VAHANVATI
Independent Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Non Executive Director : Wenjie Zhang
Additional Director : Wei Huang
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,499.60 at 04:01 PM IST on 19th Feb 2025. Gland Pharma Ltd share price was up by 2.43% over the previous closing price of Rs 1,464.00. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 24,713 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,220.95 and 52-week low share price is Rs 1,412.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 295.12 crore on a total income of Rs 1,075.84 crore for the quarter ended 2024. For the year ended Dec 2024, Gland Pharma Ltd had posted a profit of Rs 204.69 crore on a total income of Rs 1,442.55 crore.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Suven Pharma, Piramal Pharma, J B Chemicals &, Gland Pharma, Wockhardt, Pfizer, Emcure Pharma.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: